Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)
CNY 32.71
(-0.58%)
CNY 32.71
(-0.58%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 63.46 Million CNY | -69.52% |
| 2022 | 208.23 Million CNY | 163.26% |
| 2021 | 79.09 Million CNY | -80.24% |
| 2020 | 400.34 Million CNY | 16.6% |
| 2019 | 343.33 Million CNY | 33.57% |
| 2018 | 257.04 Million CNY | 471.2% |
| 2017 | 45 Million CNY | -25.0% |
| 2016 | 60 Million CNY | 0.0% |
| 2015 | 60 Million CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | -100.0% |
| 2008 | 44.2 Million CNY | 31.74% |
| 2007 | 33.55 Million CNY | 145.25% |
| 2006 | 13.68 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 30.83 Million CNY | -51.41% |
| 2024 Q2 | 28.16 Million CNY | -8.66% |
| 2024 Q3 | 60 Million CNY | 131.28% |
| 2023 Q4 | 63.46 Million CNY | -71.86% |
| 2023 Q3 | 225.54 Million CNY | 0.81% |
| 2023 Q2 | 223.73 Million CNY | 146.38% |
| 2023 FY | 63.46 Million CNY | -69.52% |
| 2023 Q1 | 90.81 Million CNY | -56.39% |
| 2022 Q1 | 194.85 Million CNY | 146.35% |
| 2022 FY | 208.23 Million CNY | 163.26% |
| 2022 Q4 | 208.23 Million CNY | 3.22% |
| 2022 Q3 | 201.73 Million CNY | -16.47% |
| 2022 Q2 | 241.52 Million CNY | 23.95% |
| 2021 Q1 | 433.47 Million CNY | 8.27% |
| 2021 FY | 79.09 Million CNY | -80.24% |
| 2021 Q4 | 79.09 Million CNY | -39.12% |
| 2021 Q3 | 129.93 Million CNY | -61.52% |
| 2021 Q2 | 337.64 Million CNY | -22.11% |
| 2020 Q4 | 400.34 Million CNY | -21.28% |
| 2020 Q1 | 508.53 Million CNY | 48.12% |
| 2020 FY | 400.34 Million CNY | 16.6% |
| 2020 Q3 | 508.59 Million CNY | -10.54% |
| 2020 Q2 | 568.53 Million CNY | 11.8% |
| 2019 Q2 | 346.04 Million CNY | 34.62% |
| 2019 Q1 | 257.04 Million CNY | 0.0% |
| 2019 FY | 343.33 Million CNY | 33.57% |
| 2019 Q4 | 343.33 Million CNY | -5.44% |
| 2019 Q3 | 363.08 Million CNY | 4.92% |
| 2018 Q4 | 257.04 Million CNY | 51.56% |
| 2018 Q3 | 169.59 Million CNY | 324.0% |
| 2018 FY | 257.04 Million CNY | 471.2% |
| 2018 Q2 | 40 Million CNY | -11.11% |
| 2018 Q1 | 45 Million CNY | 0.0% |
| 2017 Q3 | 55 Million CNY | 0.0% |
| 2017 Q2 | 55 Million CNY | -8.33% |
| 2017 FY | 45 Million CNY | -25.0% |
| 2017 Q4 | 45 Million CNY | -18.18% |
| 2017 Q1 | 60 Million CNY | 0.0% |
| 2016 FY | 60 Million CNY | 0.0% |
| 2016 Q4 | 60 Million CNY | 0.0% |
| 2016 Q1 | 60 Million CNY | 0.0% |
| 2016 Q3 | 60 Million CNY | 0.0% |
| 2016 Q2 | 60 Million CNY | 0.0% |
| 2015 Q4 | 60 Million CNY | 0.0% |
| 2015 FY | 60 Million CNY | 0.0% |
| 2015 Q3 | 60 Million CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2011 Q3 | - CNY | -100.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 Q2 | 121.9 Million CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2010 Q1 | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2009 Q3 | - CNY | -100.0% |
| 2009 FY | - CNY | -100.0% |
| 2009 Q2 | 74.6 Million CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2008 Q4 | 44.2 Million CNY | 0.0% |
| 2008 FY | 44.2 Million CNY | 31.74% |
| 2007 FY | 33.55 Million CNY | 145.25% |
| 2006 FY | 13.68 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 1.61 Billion CNY | 96.066% |
| Blue Sail Medical Co.,Ltd. | 3.85 Billion CNY | 98.354% |
| Andon Health Co., Ltd. | 1.57 Billion CNY | 95.977% |
| Allmed Medical Products Co., Ltd | 970.19 Million CNY | 93.458% |
| Improve Medical Instruments Co., Ltd. | 400.42 Million CNY | 84.15% |
| Tofflon Science and Technology Group Co., Ltd. | 6.6 Million CNY | -861.48% |
| Truking Technology Limited | 1.32 Billion CNY | 95.21% |
| Jiangxi Sanxin Medtec Co.,Ltd. | 342.85 Million CNY | 81.489% |
| Shenyang Xingqi Pharmaceutical Co.,Ltd | 91.09 Million CNY | 30.332% |
| Autek China Inc. | 344.76 Million CNY | 81.592% |
| Intco Medical Technology Co., Ltd. | 7.16 Billion CNY | 99.114% |
| Jiangsu Apon Medical Technology Co., Ltd. | 76.41 Million CNY | 16.95% |
| Winner Medical Co., Ltd. | 2.49 Billion CNY | 97.456% |
| Imeik Technology Development Co.,Ltd. | 52.46 Million CNY | -20.972% |
| Zhonghong Pulin Medical Products Co., Ltd. | 662.53 Million CNY | 90.421% |
| Caina Technology Co., Ltd. | 429.46 Thousand CNY | -14677.786% |